Atossa Therapeutics
ATOS
#10049
Rank
NZ$69.58 M
Marketcap
NZ$8.08
Share price
-1.36%
Change (1 day)
389.07%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): NZ-$0.42

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.43. In 2024 the company made an earnings per share (EPS) of NZ-$0.34 an increase over its 2023 EPS that were of NZ-$0.41.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.4222.06%
2024NZ-$0.34-16.67%
2023NZ-$0.4114.29%
2022NZ-$0.3616.67%
2021NZ-$0.31-90.86%
2020NZ-$3.38-2.96%
2019NZ-$3.48-63.09%
2018NZ-$9.43-49.63%
2017NZ-$18.72-57.87%
2016NZ-$44.42-74.01%
2015NZ-$170.91-9.18%
2014NZ-$188.19-12.86%
2013NZ-$215.9570.73%
2012NZ-$126.4934.08%
2011NZ-$94.34263.47%
2010NZ-$25.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.97-3,594.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.72-3,768.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.47-4,644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.06 148.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA